Related Experiment Video

Updated: Apr 9, 2026

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage
09:41

Intrastriatal Injection of Autologous Blood or Clostridial Collagenase as Murine Models of Intracerebral Hemorrhage

Published on: July 3, 2014

15.6K

Statins in Intracerebral Hemorrhage

Arne Lauer1, Steven M Greenberg, M Edip Gurol

  • 1Hemorrhagic Stroke Research Program, Massachusetts General Hospital - Harvard Medical School, Boston, MA, 02114, USA, alauer@partners.org.

Current Atherosclerosis Reports
|June 21, 2015
PubMed

Insights

Statins are crucial for preventing ischemic events, but their role after intracerebral hemorrhage (ICH) is debated. Emerging evidence suggests statins may improve outcomes post-ICH, warranting careful consideration of their use.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Statins are widely used for cardiovascular and cerebrovascular disease prevention.
  • Concerns exist regarding statin use and intracerebral hemorrhage (ICH) risk, potentially leading to discontinuation.
  • Preclinical and clinical data suggest statins may offer benefits beyond lipid-lowering post-ICH.

Purpose of the Study:

  • To review the evidence on statin use and ICH risk.
  • To evaluate the impact of statins on ICH outcomes and recovery.
  • To provide clinical recommendations for statin management in ICH patients.

Main Methods:

  • Review of existing preclinical and clinical evidence.
  • Analysis of studies examining statin interactions with ICH risk and outcomes.
  • Consideration of different ICH etiologies and recurrence risks.

Main Results:

  • Evidence suggests statins may have beneficial effects on ICH recovery.
  • The relationship between statins, low lipoprotein levels, and ICH risk requires further investigation.
  • Data from randomized controlled trials and prospective studies are limited.

Conclusions:

  • Clinical decisions regarding statin use post-ICH should balance potential risks with emerging evidence of benefits.
  • Individualized assessment considering ICH etiology and recurrence risk is crucial.
  • Further high-quality research is needed to clarify statin's role in ICH management.

More Related Videos

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation09:01

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Published on: October 15, 2021

8.9K
Using Zebrafish Larvae to Study the Pathological Consequences of Hemorrhagic Stroke06:36

Using Zebrafish Larvae to Study the Pathological Consequences of Hemorrhagic Stroke

Published on: June 5, 2019

8.9K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466